Skip to main content
Caplight Logo









Cellcolabs

Cellcolabs

Private
SolnaHealthcare & Life Scienceshttps://www.cellcolabs.com/

Last Round

VC Round

Oct 27, 2025

Est. Valuation

$95.94M

Total Funding Raised

$28.3M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Cellcolabs is a biotechnology company that specializes in the industrial-scale, GMP-compliant production of high-quality Mesenchymal Stem Cells (MSCs) for research and clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

mesenchymal stem cellsMSCGMP-certifiedregenerative medicinecell therapyclinical grade stem cellsAdvanced Therapy Medicinal ProductsiATMPbiotech manufacturingclinical trial supportbiobankingstem cell researchlongevity science

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellcolabs Comparables

Compare Cellcolabs with similar companies based on industry and business-model similarity.

Cellcolabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RoosterBio
82%
Histocell
74%
PromoCell GmbH
69%

Cellcolabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 27, 2025
AngelMar 5, 2024
VC RoundMar 27, 2023
Series AMar 23, 2022

Key People

Founding team and executive leadership

Vincent Metzler

Chief Executive Officer (CEO)

Executive Team

Cellcolabs Investors

Notable investors and investment history

Cellcolabs investors
InvestorRounds
TakuraVC Round, Series A
Norrsken VCAngel, Series A
Norrsken LauncherAngel, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 203% MoM, reaching 4.3K.

  • Feb 24, 2026

    Partnered with InnoHK CNRM to advance MSC therapy for knee osteoarthritis.

Cellcolabs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellcolabs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellcolabs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSolna
Employee Range77
Year Founded2021
Last FundingOct 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?